Patent Assignment
Reel/Frame 060112/0335
Assignment of Assignor's Interest
Recorded: 2022-06-06
Pages: 9
Assignor
SHIJIAZHUANG SAGACITY NEW DRUG DEVELOPMENT CO., LTD.
Executed: 2022-05-11
Assignee
WUXI BIOCITY BIOPHARMACEUTICS CO., LTD.
ROOM 315, MEILIANG ROAD NO.88, MASHAN, BINHU DISTRICT, WUXI, JIANGSU, 214000, CHINA
Covered Property
(1)
Macrocyclic Compound Serving as WEE1 Inhibitor and Applications Thereof
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.